HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Meini Selected Research

MEN 11270

4/2002In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
3/2001Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Meini Research Topics

Disease

3Chronic Limb-Threatening Ischemia
12/2016 - 03/2005
3Hyperalgesia
04/2016 - 05/2000
3Inflammation (Inflammations)
11/2013 - 05/2000
3Pain (Aches)
09/2013 - 03/2005
3Osteoarthritis
08/2012 - 12/2009
2Knee Osteoarthritis
11/2013 - 08/2008
2Synovitis
02/2011 - 12/2009
2Cystitis
01/2007 - 05/2000
2Hypotension (Low Blood Pressure)
04/2002 - 03/2001
1Ischemia
12/2016
1Myocardial Infarction
12/2016
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2016
1Colitis
04/2016
1Hypersensitivity (Allergy)
04/2016
1Arthritis (Polyarthritis)
09/2013
1Necrosis
01/2007
1Tachycardia (Tachyarrhythmias)
04/2002
1Tics (Tic)
05/2001

Drug/Important Bio-Agent (IBA)

8BradykininIBA
11/2013 - 03/2001
3Iloprost (Ventavis)FDA Link
12/2016 - 03/2005
32,5-dichloro-4-bromophenol (B 2)IBA
08/2012 - 03/2001
2(4- amino- 5- (4- (4- (2,4- dichloro- 3- (2,4- dimethyl- 8- quinolyloxymethyl)phenylsulfonamido)tetrahydro- 2H- 4- pyranoylcarbonyl)piperazino)- 5- oxopentyl)(trimethyl)ammoniumIBA
09/2013 - 08/2012
2KininsIBA
01/2007 - 04/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007 - 11/2005
2icatibantIBA
04/2002 - 03/2001
2MEN 11270IBA
04/2002 - 03/2001
1Oxygen (Dioxygen)IBA
12/2016
1Carbon DioxideIBA
12/2016
1ibodutantIBA
04/2016
1AcidsIBA
04/2016
1Ethanol (Ethyl Alcohol)IBA
04/2016
1TachykininsIBA
04/2016
1Biomarkers (Surrogate Marker)IBA
11/2013
1CarrageenanIBA
09/2013
1Pharmaceutical PreparationsIBA
09/2013
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2007
1Annexin A5IBA
11/2005
1Propidium (Propidium Iodide)IBA
11/2005
1Epoprostenol (Prostacyclin)FDA LinkGeneric
11/2005
1Messenger RNA (mRNA)IBA
11/2005
1Interleukin-6 (Interleukin 6)IBA
11/2005
1CytokinesIBA
11/2005
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2005
1Type II Tumor Necrosis Factor ReceptorsIBA
11/2005
1AminopeptidasesIBA
04/2002
1Cyclic PeptidesIBA
04/2002
1octahydroindole-2-carboxylic acidIBA
05/2001
1Proline (L-Proline)FDA Link
05/2001
1Peptides (Polypeptides)IBA
03/2001
1Peptide Receptors (Peptide Receptor)IBA
03/2001
1FR 173657IBA
03/2001
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
05/2000
1dexketoprofen trometamol (Keral)IBA
05/2000
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2000
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2000
1IsoenzymesIBA
05/2000
1EndotoxinsIBA
05/2000
1ProstaglandinsIBA
05/2000

Therapy/Procedure

2Aftercare (After-Treatment)
09/2013 - 03/2005
1Rectal Administration
04/2016
1Therapeutics
08/2012
1Intravenous Infusions
03/2005
1Topical Administration
04/2002